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ABSTRAC'r 
BK virus large T antigen expression was correlated 
with the ability of BK virus transformed hamster cells to 
release infectious virus after fusion with permissive human 
embryonic kidney cells. Seven clones of BK virus infected 
BHK-21 cells (BK-BHK) were isolated from agar suspension 
cultures when cell colonies grew to 1 mm to 2 mm in size. 
All of the BK-BHK clones initiated tumors in Syrian hamsters 
and maintained high plating efficiencies in 0.33% agar 
suspension. Large T antigen was detected in 4 of the BK-
BHK clones using immunofluorescence and immunoperoxidase 
assays. Infectious BK virus was rescued from 3 of the 
BK-BHK clones following cell fusion. One clone, BK-BHK-129, 
was demonstrably large T antigen negative, but released 
infectious BKV following cell fusion. Subclones of the BK-
BHK-L-29 clone were also large T antigen negative virus 
yielders. However, the rescued virus was capable of trans-
forming BHK-21 cells with an efficiency comparable to wild 
type BK'virus. Large T antigen was detected in BHK-21 cells 
transformed by the rescued virus. The rescued virus DNA 
was examined by inspection of restriction endonuclease 
digestion fragments on agarose gels and by s1 nuclease 
digestion following hybridization to wild type BK virus DNA. 
The rescued virus was indistinguishable from wild type 
virus using these techniques. 
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Introduction 
One of the most widely studied groups of viruses which 
possess in vitro cell transforming ability and oncogenic 
activity in animals are the papovaviruses. The papova-
virus group includes viruses of rodent and primate origin. 
The rodent polyoma virus was isolated from inbred strains 
of mice in 1953 by Gross (33), and was found capable of 
inducing multiple types of tumors in hamsters and mice (91). 
The primate papovaviruses consist of the simian virus 40 
and two human groups, the papilloma and the BK and JC virus 
group. Simian virus 40 (SV40) was isolated from rhesus 
monkey cells and was shovm to induce tumors when injected 
into hamsters (2,22,97). In vitro SV40 is capable of malig-
nantly transforming human, mouse, rat, and hamster cells 
(48,50). The human papilloma virus has been shown to in-
duce benign tumors (112). The human papovaviruses BK and 
JC were isolated from immunologically compromised hosts. 
BK virus (BKV) was isolated from the urine of a renal allo-
graft recipient (25)Whereas JC virus (JCV) was first detect-
ed in brain cells of patients suffering from progressive 
multifocal leukoencephalopathy (PML) (6?). BKV has been 
shown to be oncogenic in newborn hamsters (18,61,80,100) 
although the ability to induce tumors varies between isolates. 
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For example, the original BKV isolate has a low incidence 
of tumor induction varying between 1% and 4% (80) whereas 
another isolate, designated RF, has a high incidence of 
tumor induction of app~oximately 50% (18). However, there 
is no difference between the genomes of the original BK 
and RF isolates (5?). In vitro BKV can malignantly trans-
form hamster, rabbit, mouse, and monkey cells (10,54,56, 
69,70). The JC isolate is highly oncogenic in newborn ham-
sters(6?). 
The SV40, polyoma, BK, and JC viruses possess similar 
physical properties. They are composed of circular duplex 
supercoiled DNA with molecular weights in the range of J.2-
J.4 x 106 daltons (2J). The DNA is enclosed in a 45 nm 
icosahedral protein capsid. Due to the small size of the 
genome, these viruses can code for only five or six proteins 
and rely heavily on host cell functions for replication and 
tr~scription during their lytic cycle. 
Cells in which viral infection culminates in virus 
production such as cells of the natural host, are termed 
permissive. Papovaviruses can also infect cells of other 
species termed non-permissive cells, which do not support 
the replication of the virus. Instead, infection of these 
cells results occasionally in their transformation to a 
malignant phenotype by a process that requires the expres-
sion of at least one viral gene. 
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The productive infection by a papovavirus begins with 
adsorption and penetration of the cell by the virus. This 
is followed by uncoating of the nucleic acid. The ensuing 
lytic cycle has been divided into two phases, early and late. 
The early phase lasts until the beginning of DNA replication. 
During this phase, 19S virus specific early mRNA is synthe-
sized. This 19S mRNA encodes the tumor or T antigens. 
The T antigens are nonstructural virus proteins found in 
the nucleus of lytically infected and transformed cells 
(7,24,31,34,35,36,72,100). At this time, there appear to 
be two T antigens; large T antigen (molecular weight 
90,000) and small t antigen (molecular weight 17,000) 
(15,73). It has been shown that large T antigen binds to 
viral DNA specifically at the origin of DNA replication, 
indicating a possible role in viral DNA replication (3,13, 
43,74,87,102). Studies employing conditional lethal mu-
tants of SV40 have indicated that the large T antigen may 
also be necessary for the initiation and maintenance of cell 
transformation (11,47,55,66,102). Similar studies of 
SV40 deletion mutants have demonstrated that small t anti-
gen may also be necessary for cell transformation (8,86). 
Structurally, the T antigens of SV40 and BKV share several 
tryptic peptides and are therefore related (19,58,75,76, 
84,85). 
A map of the SV40 genome is presented in Figure 1. 
The map is divided into 100 minutes with reference to the 
4 
Origin of DNA replication 
(residues 5118-5197) 
Codons for t(residues 
5081-4559) and T antigens (residues 5081-4837) 
Sequence~ absent 
in large T mRNA (residues 4491-
4836) \ 
Leader linked to 19S mRNA (residues 243-289) & to 
VP1 16S mRNA(residues 243-445) 
VP2 codons(residues 480-1535) 
Sequences.absent 
in small t mRNA 
(residue~ 4491-
Late 
mRNA 
VP3 codons(residues ~ 834-1535) 
4556) 
Termination 
in all 3 phases 
(residues 4559-
4592) 
Main body of codons 
for T antig~n (residues 4490-2612) 
\ 
Termination of T antigen (residue 2611) 
Termination of 
____ VP
2 
& VPJ 
(residue 1536) 
VP1 codons(residues ~ 1423-2508) 
Termination of VP1 (residue 2509) 
Fifmre 1 Schematic Representation of the SV40 Genome 
(adapted from Reddy et al. (73)~ 
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EcoRI restriction endonuclease cleavage site. The origin 
of DNA replication and mRNA transcription is located at 0.67 
on the map. Early mRNA is transcribed in a counterclock-
wise direction from the E strand of DNA. Late mRNA is 
transcribed in a clockwise direction from the opposite 
or L strand of DNA. Transcription for both phases terminates 
at 0.17 on the map. 
Recently, several paradoxical observations have been 
made concerning the two early gene products. The basis 
of this paradox is that nearly the entire early region 
(2500-2600 nucleotides) would be required to encode a pro-
tein with a molecular weight of 90,000 (5). Yet large dele-
tions within the early region mapping between 0.54 and 0.59 
map units do not result in the production of an altered 
large T antigen (79,81). These deletion mutants fail either 
to induce a detectable small t antigen or induce an altered 
protein that has a decrease in molecular weight rcughly 
corresponding to the size of the deletion (15). There-
fore, the sequences mapping between 0.54 and 0.59 code 
exclusively for portions of small t antigen. In addition, 
sequencing studies of SV40 DNA have shown that a transcript 
of the early region would contain at least two termination 
codons in each of the three reading frames near map position 
0.54 (104). Both early proteins can be translated in vitro 
from mRNA sedimenting at 19S. The small t antigen mRNA sed~ 
6 
ments slightly faster than the large T antigen mRNA 1(5). 
These two mRNA molecules must therefore contain extensively 
overlapping sequences. Each of them is approximately the 
size of the early region (5). Small t antigen shares a 
considerable fraction of its amino acid sequence with the 
large T antigen (71). This suggests that portions of the 
two proteins are encoded in the same DNA sequences. 
A resolution to this paradox has been developed. 
Sequences comprising covalently continuous viral mRNA 
molecules may arise from well separated regions on a viral 
genome (1,4,14,46). These molecules arise by a splicing pr~ 
cess (5). Subsequently, Berk and Sharp (5) demonstrated 
that the two early SV40 mRNA species were spliced in such 
a way that would account for the shared amino acid sequences 
of large and small T antigens; the occurrance of termination 
codons at 0.5l} map units; the phenotypes of vari?us deletion 
mutants; and the relative size of both the T antigens and 
the mRNA transcripts encoding them (5). Subsequent sequence 
studies have verified their hypothesis (106). Similar 
studies have been carried out with BKV, and the data appears 
to be similar (Dhar, personal communication). 
The late phase of the infective cycle is marked by the 
onset of viral DNA replication and the synthesis of 16S 
and 19S virus specific mRNA encoding the virus structural 
proteins. The major structural proteins, VPl, of SV40 and 
BKV are somewhat related (3,18,53,59,113). Tryptic peptide 
--
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analysis indicates several similar peptides (3,53,59,113). 
This similarity accounts for the serological neutralizing 
crossreactivity of SV40 and BKV. The lytic cycle terminates 
in the assembly, maturation, and release of progeny virus. 
The DNA of SV40 and BKV has been compared by restirction 
endonuclease cleavage analysis, hybridization, and DNA se-
quencing. The DNAs from SV40 and BKV have distinct restric-
tion endonuclease cleavage patterns (38). From reassociatim 
kinetics. it was concluded that there was an 11-12% sequence 
homology between BKV and SV40 DNA (38,39,40,45,65). This 
homology was localized in the late region in the portion of 
the genome coding for VPl. No homology was detected between 
the early regions of sv4o and BKV DNA (38,39,40,45,65). 
These results were consistent with the minor crossreactiv-
ity between sv4o and BKV structural antigens. It did not 
explain the strong crossreactivity of the early non-struc-
tural T antigens. Newell, et al., (62), utilized a more 
sensitive, but less stringent test for examining DNA 
homologies. The two DNA molecules were jointed at a restri~ 
tion endonuclease cleavage site common to both DNAs. The 
DNA was allowed to hybridize or "snap back". Using this 
technique, extensive homology in the early region was de-
tected (62). It had been postulated that the non-homology 
between the early regions of SV40 and BKV DNA was due to 
the degeneracy of the genetic code(45). The degenerate 
sequences might still code for a serologically crossreactive 
8 
protein. Recent DNA sequencing work seems to support this 
hypothesis (16,106,114, Dhar, personal communication). 
The entire SV40 genome has been sequenced (l?,?J,9J,94,95, 
96,10J,l06,115). Preliminary work on the DNA sequence of 3KV 
indicates extensive homology in the early region (16,106, 
114, Dhar, personal communication). Yet the sequences differ 
enough so that hybridization under stringent conditions 
might not detect nucleotide homology in this region (16, 
106, 114). 
One of the primary interests in papovavirus research 
is the relationship of the virus to its tumor or transformed 
cells. Gerber and Kirschstein (JO) investigated the rela-
tionship of SV40 to the formation of ependymomas in hamsters 
It was observed that cell-free tlli~or extracts failed to yield 
infectious virus. Hov:ever, infectious virus could be con-
sistently demonstrated when tumor cells were seeded onto 
monolayers of permissive cells. These observations were con-
firmed by other investigators (6,77). Subsequently, evi-
dence was presented which suggested that the viral genome 
was permanently present in an altered state in some of the 
tumor cells (2?,28). Virus release from tumor cells seeded 
onto permissive cell monolayers could be enhanced by the 
addition of UV-inactivated Sendai virus (29). This result-
ed in cell fusion and the formation of virus producing hetero-
karyons. Koprowski et al (49) postulated that the entire 
SV40 genome was present in the tumor cells, but was unable 
- 9 
to be completely expressed. Fusion with permissive cells, 
resulting in the formation of heterokaryon cells, supplied 
a function missing in the transformed cells which allowed 
co~plete expression of viral genes and release of infectious 
virus (49,108). This phenomenon of virus production after 
fusion with permissive cells was termed virus rescue. The 
failure of a tumor cell line to release infectious virus 
was explained in several ways (21). Only a fragment of the 
SV40 genome was integrated into these nonyielder cells. 
Alternatively, the complement of viral or cellular genes 
might contain mutations which blocked the reversal of either 
the integrated state, viral replication, or both. Finally, 
the incidence of fusion with susceptible cells might be too 
low. Subsequently; several investigators presented strong 
evidence that the transformir:g viral genome persists in an 
integrated state in the transformed cells (12,26,77,78,99, 
109,111). Analysis of DNA reassociation kinetics suggested 
that there is one SV40 genome per host cell genome (26). 
SV40 rescued from extensively passaged transformed cells 
is indistinguishable from the wild type in that is has 
the same markers associated with the original transforming 
virus (101). Later investigations of this phenomenon by 
Huebner, et al (41), resulted in the isolation of defective 
SV40 from transformed cells after cell fusion. The rescued 
virus had a buoyant density in CsCl expected of deletion 
mutants. These studies indicated that the entire genome 
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of SV40 might not be present in certain svho transformed 
cells. If the entire genome was present, then it must exist 
in a form which could not be properly excised. Evidence 
presented by Boyd and Butel (9) suggest that it is not the 
resident genome, but excision which is defective. 
Presently, little is known about the regulation of 
BKV gene expression in BKV transformed cells. It is thought 
that BKV large T antigen is necessary for viral DNA replica-
tion and cell transformation in analogy with its SV40 counter-
part. However, we have noted that the T antigen response of 
BKV transformed baby hamster kidney cells (BK-BHK) is weak 
as measured by immunofluorescence assay, although the cells 
maintain a transformed phenotype. Antisera produced against 
BK-BHK cells have a low reactivity against BKV T antigen. 
Based on these observations, we undertook studies to 
determine the relationship between T antigen expression and 
the virus rescuability in BK-BHK cells. During these studies, 
the novel cell clone, BK-BHK-L-29, was isolated which is 
demonstrably T antigen negative yet releases infectious BKV 
following cell fusion. The rescued virus has been characte~ 
ized for its ability to transform cells and induce T antigen 
expression . 
. 
Through restriction endonuclease mapping and DNA-DNA 
hybridization, the rescued virus has been compared with wild 
type BKV. The results of these experiments are presented 
here. 
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It now appears that the isolation of the BK-BHK-L-29 
clone may provide a model system to study the functions of 
BKV early gene products in its transformed cells. 
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Materials and Methods 
Reagents: Phosphate buffered saline (PBS) pH 7.2 
contains 350 mM NaCl, 2.6 miir KCl, 1.6 rru'V1 NazHF04, 0.4 mM 
WgC12 , and 0.9 mM CaC12 • TD buffer pH 7.0 consists of 137 
mM NaCl, 5 ml\1 KCl, 0. 7 mM NaH2POLJ-, and 25 rru"VI tris (hydroxy-
ethyl)aminomethane (Tris). Versene buffer pH 7.1 consists 
of 0.6 mM ethylenedia~inetetraacetic acid (EDTA), 13.7 
mM NaCl, 3 mM KCl, 8 ml\1 Na2HP04, and 1 mM KHzP04. TES 
buffer pH 7.2 is 10 mM Tris, 10 mm NaCl, and 10 mM EDTA. 
Alsevers buffer is 0.11 M D-glucose, 0.027 M sodium citrate, 
and 0.071 M NaCl pH 6.8. 
Dulbecco' s modified Eagle medium (Dr.lE), fetal calf 
serum (FCS), and calf serum (CS) were purchased from Flow 
Laboratories. Fluorescein-labelled rabbit anti-hamster IgG 
was purchased from Cappel Laboratories. DE-52 ion exchange 
resin was obtained from vrnatman Co. Sephadex G-100 was 
' 
obtained from Pharmacia Chemicals. Horseradish peroxidase 
type VI was purchased from Sigma Chemical Company. The 
restriction endonucleases Eco RI, Hpa II, and Hind III were 
purchased from New England Biolabs ·while endonuclease s1 
was obtained from Miles I.aboratories. 
Cell Cultures: Mouse 3T3 cells (Balb c/3T3), first 
established by Todaro and Green (105), African green monkey 
kidney cells (BSC-1), and rat fibroblast cells were contin-
lJ 
uously propagated as established cell lines in Dtlli supple-
mented with 10% FCS. Polyoma transformed rat cells (Py-2403), 
human embryonic kidney cells (HEK), and a continuous line 
of human cells, HEK-JTJ-L-9 were also propagated on DME 
containing 10% FCS. 
Baby hamster kidney cells (BHK-21), initially estab-
lished by Stoker and Macpherson (92), hamster fibroblast 
cells (HF), BKV transformed BHK-21 cells, and BKV trans-
formed hamster fibroblast cells (RF-194) were propagated 
on DNlli supplemented with 10% CS and 10% tryptose phosphate 
broth (TPB). 
Virus growth and purification: For preparation of BKV 
stocks, HEK cells were infected at a multiplicity of infec-
tion (moi) of 0.1 (79). Virus was harvested 18 days later 
when virtually all of the cells showed cytopathic effects. 
Virus was purified as described by Wright and di Mayorca 
(llJ). The viral lysates were subjected to six cycles of 
freezing and thawing in a dry ice-acetone bath, and were 
! 
treated with 0.2% sodium deoxycholate for 1 hr at J?C., 
Large debris were removed by centrifugation for 15 min at 
10,000 g. The supernatant was centrifuged at 20C for 4 hr 
at 64,000 g in a Beckman SW-25.2 rotor over a cushion of 
10 ml of saturated KBr solution in TD buffer. Virus from 
the supernatant fluid would sediment in the KBr, as a 
steep gradient is established during centrifugation. The 
.... 
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virus formed a visible band in the KBr which was collected 
and dialyzed against TD buffer. The volume of the dialyzed 
material was brought to 7.5 ml with TD buffer and added to 
3.45 g CsCl. The solution was centrifuged at 20 C for 18 
hr at 74,000 gin a Beckman type 50 rotor. The single virus 
band was collected, dialyzed against TD buffer, and stored 
at -70 C. 
Wild type SV40 and SV40 dl 1635, which contains a 55 
base pair deletion between 0.715 and 0.73 units on the SV40 
map, were propagated on BSC-1 cells and purified as described 
for BKV. Polyoma virus was propaged on Balb c/3T3 cells and 
purified similarly. 
Sendai virus was grown in specific pathogen-free 10 
day old embryonated chicken eggs obtained from SPAFAS Co. 
(48,109). Eggs were infected with 128 hemagglutinating units 
(HAU) of virus and incubated for 72 hr at 37 C. The allantoic 
fluids were collected, pooled, and centrifuged at 1000 g 
for 10 min. The supernatant was collected and centrifuged 
at 46,000 g for 30 min, and the pellet resuspended to 0.1 
the original volume in TD buffer. The virus suspension was 
refrigerated overn~ght at 4 C followed by centrifugation at 
1000 g for 10 min. The supernatant was collected and assayed 
for virus by hemagglutination of guinea pig erythrocytes. 
Sendai virus was stored at -70 C. 
Plague Assay: Virus was serially diluted in Dr~ , 
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after which 0.4 ml of each dilution inoculated in triplicate 
onto cell monolayers. BKV was titrated in this manner on 
HEK cells. SV40 was plaqued on BSC-1 cells. Polyoma virus 
was plaqued on 3alb c/3T3 cells. The virus was adsorbed 
for 2 hr at 37 C. A 9 ml over layer of 1% agar in DIIIE sup-
plemented with 1% FCS was applied and the cultures kept at 
37 c. At either 18 days post infection (PI) for BKV, or 10 
days PI for SV40 or Polyoma, the monolayers were overlayered 
a second time with 5 ml of 1% agar, 1% FCS, and 0.005% 
neutral red dye in nnm. The cultures were examined for 
plaques 24 hr later. The neutral red dye is taken up only 
by viable cells; therefore, viral plaques are readily 
detected. 
For plaque neutralization assays, 100 pfu of sample 
virus were incubated with serial dilutions of either 
rabbit hyperimmune anti-viral serum or normal rabbit serum 
for 1 hr at 37 C. The virus samples were then plaqued on 
appropriate cell monolayers. For serological identifica-
tion of virus, the neutralization of viral infection was 
calculated by plaque reduction after incubation of virus 
with virus specific antisera. 
Infectious Center Assay: BKV-transformed and normal 
cells were serially diluted in DME and 0.5 ml of each 
dilution inoculated in triplicate onto HEK cell monolayers. 
After 2 hr at 37 C, 9 ml of DNffi containing 1% agar and 1% 
FCS was applied. Cultures were kept at 37 C for 3 weeks. 
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At this time, a second overlayer consisting of DME, 1% 
agar 1% t<'•"S ' " , 0 - v and 0.005% neutral red dye was applied. 
Cultures were examined for plaques resulting from infectious 
centers 24 hr later. 
Hema~glutination Assay: Human type 0 erythrocytes were 
washed once with PBS pH ?.8. Hemagglutination assays 
were done in microtiter plates. Virus was serially diluted 
in Alsevers buffer pH 6.5. The total volume of each sample 
was 0.1 ml, to which 0.05 ml of a 4% v/v erythrocyte solu-
tion was added. The samples were refrigerated overnight 
at 4 C and examined the following day for hemagglutination. 
Hemagglytination Tnhibition Assay: For serological 
identification of BKV, anti-BKV serum #K-44-4 was used to 
inhibit hemagglutination of human type 0 erythrocytes (53). 
Experimentally, 0.1 ml anti-BKV serum was incubated at 
56 C for 1 hr. This was followed by the addition of 0.2 
ml 0.01 M KI04 and subsequent incubation for 30 min at 
room temperature. The serum was serially diluted in micro-
titer wells and challenged with 8 hemagglutinating units 
(HAU) of unknown virus. After 30 min at room temperature, 
human type 0 erythrocytes were added and the samples refrig-
erated overnight at 4 c. A decrease in hemagglutination 
titer of 4-fold or greater was considered to serologically 
identify an unknown virus as BKV. 
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Transformation of Cells in SoTt Agar: The procedure 
for transformation of cells in soft agar is described by 
MacPhearson and Montanier (52). The cells were harvested 
by treatment with 0.5% trypsin and suspended in TD buffer 
pH 6.8, supplemented with 1% FCS at a concentration of 1 
x 106 cells per 0.1 ml. A 0.05 ml portion of this cell 
suspension containing 5 x 105 cells was pipetted into a 
small test tube. To each test tube was added 100-200 PFU/ 
cell of virus. The volume was adjusted to 0.5 ml with TD 
buffer pH 6.8, and the virus-cell suspension incubated at 
37 C for 1 hr with continuous stirring. After adsorption, 
any cell clumps were broken up by pipetting in a Pasteur 
pipette drawn out to capillary size. From this suspension, 
0.2 m1 was added to 4.8 ml of Eagle's diluent consisting 
of 80% DME, 10% calf serum that had been filtered through 
a 0.4 mm millipore filter, and 10% tryptose phosphate broth 
(TPB). This suspension was combined with 10 ml of semi-
solid agar containing 40% 2X DME, 10% filtered calf serum, 
10% TPB, and 40% of a 1.275% solution of agar, bringing the 
final agar concentration to 0.33%. From this suspension, 
1.5 ml containing 2 x 104 cells were pipetted onto the cen-
ters of petri dishes containing a 5 ml layer of 0.5% agar 
supplemented with 10% CS and DfJIE. Cultures were checked 
periodically for colonies which appeared after approximately 
3 to 4 weeks incubation at 37 C. Colonies of cells were 
picked from the agar with a Pasteur pipette and grown in 
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m.m supplemented with 109~ CS and 10;1, TP3. 
Plating Eff'iciency o·f' Trans formed Calls: The trans-
formed cells were harvested and suspended in TD buffer pH 
6. 8 to a concentration of 5 x 104 cells/ml. A 0. 2 ml por-
tion of this suspension was mixed with 4.8 ml of Eagle's 
diluent. This suspension was added to 10 ml of semi-solid 
agar and 1.5 ml of the resulting mixture was pipetted onto 
petri dishes containing 5 ml of solid agar. The cultures 
were incubated for 3 to 4 weeks after which the colonies 
were counted and the plating efficiencies determined as 
a percentage of the total number of cells plated. 
Tumorigenicity of Transformed Cells: Transformed 
cells were harvested with versen.e buffer pH 7.0, resuspended 
in PBS buffer pH 7.2, and 1 x 105 cells inoculated subcu-
taneously between the shoulders of 2 to 3 week old male 
Syrian hamsters. When tumors had formed, the animals were 
bled by cardiac puncture, sacrificed, and the tumors ex-
planted. To explant tumor tissue for culture, the area 
around the tumor was swabbed with 70% ethanol and the skin 
around the tumor cut with sterile scissors. The tumors were 
removed and washed ·with DME. Connective tissue, fat, and 
blood vessels were removed by scraping with a scalpel. 
The dissected tumor tissue was washed again with Dl\TE,and a 
small piece of solid tumor tissue removed and minced finely 
with a scalpel. The tissue was broken up further by pipet-
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ting and the tissue suspension distributed to petri dishes 
containing Dr.'IE, 10% CS, and 10% TPB. '.\'hen the explanted 
cells had grown to confluency, they were harvested with 
versene buffer pH 7.0, and stored in liquid nitrogen. 
The sera collected from tumor-bearing animals were tested 
for activity against BKV T antigen by immunofluorescence 
assay. Those sera with anti-T antigen reactivity were 
pooled and used in assaying for T antigen in BKV transformed 
cells. 
Rabbit Skin Biousies: Rabbits were anesthesized with 
U;I injections of Inovar at a dosage of l ml for the first 
3 kg of body weight and 0.1 ml for every 0.3 kg there-
after. An area on the neck was shaved and swabbed with 
betadine. A small piece of skin was removed with a pair 
of sterile scissors. The skin explant was minced with scis-
sors and immersed in 0.5% trypsin for 20 min. ?he cells were 
collected by centrifugation and grown on D~lli supplemented 
with 10% FCS. 
Immunofluorescence Assay: The immunofluorescence assay 
for T antigen is a modification of that described by Pope 
and Rowe ( 68). Cells to be examined vrere grown on cover-
slips for 48 hrs. Coverslips were washed twice for 3 min 
each with PBS pH 7.1 and fixed in acetone for 5 min at 
-20 C. The cells were immediately washed 3 times with PBS 
for 3 min each. Coverslips were incubated with a 1:5 
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dilution of hamster anti-BKV-T antigen antisera (see 
procedure above) for 1 hr at 37 c. Coverslips were washed 
twice for 3 min each with PBS and incubated with a 1:5 
dilution of fluorescein-labelled rabbit anti-hamster 
IgG (Cappel) for 1 hr at 37 C. The coverslips were washed 
as before, mounted in glycero~and examined under a Leitz 
ultraviolet microscope. 
Serum Absorptions: Cultured cells were harvested and 
subjected to 6 cycles of freezing and thawing in a dry ice-
acetone bath. The lysate was centrifuged at 1000 g for 
5 min and the pellet used for absorption of antibody. A 
pellet containing 107 lysed cells was resuspended in 0.5 
ml serum. The serum was incubated for 2 hr at 37 C. The 
cells were removed by centrifugation and the absorption 
repeated once with fresh cell lysate. 
Hamster antiperoxidase: Hamster antiperoxidase antibody 
was prepared according to the method of Dougherty et gl. 
(20). A 5 mg/ml solution of horseradish peroxidase in PBS 
buffer pH 7.2 was prepared and mixed with an equal volume 
of Freund's complete adjuvant. For inoculation, 0.2 ml 
containing 1 mg horseradish peroxidase was injected intra-
muscularly into the hind leg of 2 to 3 week old female 
Syrian hamsters. After 14 days, the hamsters were injected 
with 0.5 mg of horseradish peroxidase in Freund's incom-
plete adjuvant (0.2 ml per injection). On day 28, the 
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hamsters were injected intraperitoneally with 0.2 mg horse-
radish peroxidase in 0.2 ml PBS buffer pH 7.2. Six days 
later the hamsters were bled by cardiac puncture, and the 
individual sera tested for peroxidase activity. The sera 
were pooled and stored at -20 c. 
To estimate the equivalence point of the antiperoxi-
dase antisera, various quantities of peroxidase were mixed 
with 0.2 ml portions of hamster antiserum and were incubated 
for 48 hr at 4 C. The immune precipitates were collected 
by centrifugation at 27,000 g for 20 min, and washed once 
with cold isotonic saline. The precipitate was dissolved 
by addition of 1 drop of 0.1 N NaOH and diluted to 1 ml 
with saline. The protein concentration of the immune preci-
pitates was determined by the method of Lowry (51). Super-
natant fluids were analyzed for excess antigen or antibody 
by diffusion in agar. 
Preparation of Peroxidase-antiperoxidase (PAP) Com-
~: The procedure for the preparation of the PAP complex 
follows that of Sternberger et al. (90). An equivalent 
amount of peroxidase, previously determined to be 0.625 mg/ 
ml was added to 1 ml of hamster antisera and incubated for 
2 hr at 37 C. The immune precipitate was collected by centri-
fugation at 27,000 g for 20 min, washed 3 times with iso-
tonic saline, and was resuspended in 2 ml of isotonic 
saline containing 6.25 mg of peroxidase. The pH was ad-
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justed to 2.3 by addition of 0.1 N HCl to dissolve the immune 
precipitate and was immediately neutralized to pH 7.2 with 
0.1 N NaOH and 1 ml of a solution of 0.08 N sodium acetate 
and 0.15 N ammonium acetate. An equal volume of cold sat-
urated (I'TI{4 )2so4 was slowly admixed to the solution. The 
mixture was stirred for 25 min, and the precipitate collect-
ed by centrifugation at 37,000 g for 15 min. The precipi-
m\ oJ. 
tate was washed once with 0.5Vsaturated (~lli4)zS04, dis-
solved in isotonic saline, and dialyzed against 6 1 of cold 
isotonic saline for 48 hr at 4 C. The PAP complexes were 
tested for activity by mixing 0.1 ml PAP solution with 
0.1 ml of a solution containing 25 mg of 3,3'-diaminobenzi-
dine hydrochloride, 50 ml TD buffer pH 6.8, and 0.15 ml 
of a 3% solution of hydrogen peroxide. Enzyme activity was 
indicated by the development of a brovm color. 
Isolation of Hamster IgG: Hamster IgG was isolated 
by-the method of Stanworth (88). DEAE-cellulose (DE-52, 
Whatman) was equilibrated with PBS pH 7.5. The exchanger 
was cooled to 4 C and excess buffer removed by applying a 
vacuum. The moist exchanger was stirred into hamster serum 
which had been previously equilibrated against PBS pH 7.5 
(7 g wet exchanger per ml serum). The mixture was refrig-
erated at 4 C for 2 hr with occasional stirring. An equal 
volume of cold PBS pH 7.5 was added and the liquid phase 
collected by filtering over a vacuum. The filtrate was 
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concentrated by ultrafiltration and analyzed for purity by 
reaction with rabbit anti-hamster IgG and rabbit anti-
hamster serum (Cappel). 
Preparation of Rabbit Anti-hamster IgG: Rabbits were 
inoculated with 0.1 mg purified hamster IgG in complete 
Freund's adjuvant at 4 different sites. Ten days later, 
0.07 mg hamster IgG was administered intravenously. The 
rabbits were bled 10 days later. The anti-hamster IgG 
activity of the serum was checked by agar diffusion. 
Conju~ation of Horseradish Peroxidase (HRPO) and 
Hamster IgG: The procedure for conjugation is that describ-
ed by Nakane and Kawaoi (60). Five milligrams of HRPO 
were dissolved in 1.0 ml of freshly prepared 0.3 M NaHC03 
pH 8.1. To this solution, 0.1 ml of a 1% solution of 
fluorodinitrobenzene in 100% ethanol was added and the 
mixture stirred gently for 1 hr at room temperature. A 
-1.0 ml aliquot of 0.06 M Nai04 was added and the solution 
stirred for 30 min at room temperature. One ml of 0.16 
M ethylene glycol was added and the solution stirred for 1 
hr at room temperature. The solution was dialyzed against 
3 one-liter changes of 0.05 M carbonate buffer pH 9.5 at 
4 C. After.dialysis, 3 mg of hamster IgG were added and gent-
ly mixed for 3 hr at room temperature. Following incubation 
with IgG, 3 mg NaBH4 were added and the solution refrigerat-
ed overnight at 4 C. The HRPO-IgG conjugate was dialyzed 
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against PBS pH 7.1 at 4 C overnight. rrhe HRPO-IgG conju-
gate was purified on an 82 em x 1.5 em Sephadex G-100 
column equilibrated in PBS pH 7.1. Fractions were collect-
ed and the optical densities of the fractions taken at 40J 
nm and 280 nm. The fractions from the first peak were 
pooled and used in all subsequent assays. 
Immunoueroxidase Staining for BKV Large T Antigen: 
Cell cultures grmvn on glass coverslips were washed 3 times 
for 3 min each with Hanks BSS buffered at pH 7.4 with 
0.05 M Tris (Flow Laboratories). The cells were fixed by 
immersion in 95% ethanol for 5 min followed by acetone for 
5 min. The coverslips were washed with PBS and flooded with 
hamster anti-BKV-T antiserum for 10 min at 20 C. The cover-
slips were washed 3 times for 3 min each with PBS and flooded 
with rabbit anti-hamster IgG for 10 min at 20 C. The cover-
slips were washed as before and treated with peroxidase 
conjugated hamster IgG (obtained from Dr. R.IVI. Dougherty) 
for 10 min at 20 C. After washing aa before, the cells 
were refixed for 20 min in 2.4% glutaraldehyde in PBS pH 
7.2. The coverslips were washed twice with PBS and the 
bound peroxidase was visualized by the method of Graham and 
Karnovsky (32). The stained coverslips were dehydrated in 
100% ethanol and mounted in permount. 
Sendai Virus Inactivation: Sendai virus was inactivat-
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ed with0-propiolactone (BPL) as described by Steplewski 
and Koprowski (89). BPL (Sigma Chemical Co., St. Louis, Mo.) 
was added at a final concentration of 0.0125% and mixed well. 
The virus mixture was re~rigerated at 4 C for 24 hr followed 
by incubation at 37 C for 30 min. The titer of the inacti-
vated virus was determined by hemagglutination of guinea 
pig erythrocytes. Viability was tested by inoculation into 
the allantoic cavity of embryonated chicken eggs. Inactivat-
ed virus was stored at -70 C. 
BPL was tested for toxicity on cultured cells. Serial 
dilutions of BPL were inactivated at 37 C for 30 min, and 
0.5 ml of each dilution inoculated onto BHK-21 cell mono-
layers. After overnight incubation at 37 C, the cells were 
-·r·~> 
harvested:counted, and the plating efficiency calculated 
as the number of colonies divided by the number of cells 
plated, multiplied by 100. 
Sendai-mediated Cell Fusion: The procedure for Sendai-
mediated cell fusion has been described. previously by Harris 
and 'Natkins (36). For fusion, 1 x 106 virus-transformed 
cells were mixed with 2 x 106 permissive cells. The cells 
were fused by addition of 5000 hemagglutinating units of 
BPL-inactivated Sendai virus. The samples were refrigerat-
ed at 4 C for 10 min followed by incubation at 37 C for 
20 min. Each sample was plated out and maintained on DME 
supplemented with 5% FCS. After 7 days, the cultures were 
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assayed for infectious virus. The cell cultures were scraped 
from the plates and subjected to 3 cycles of freezing and 
thawing in a dry ice - acetone bath. The lysates were 
assayed for infectious rescued virus by plaquing.the sus-
ceptable cells. 
PEG-DMSO Fusion of Cells: The protocol for cell fu-
sion with PEG-DMSO has been described by Norwood et al (64). 
The cells to be fused were harvested and plated in mixed 
culture at a ratio of 2:1, permissive:transformed on 60 
mm x 15 mm petri dishes, and allowed to grow for 2h hr. 
For fusion, 16 g PEG (molecular weight 6,000) were auto-
claved for 15 min at 15 lbs pressure. This was mixed while 
still hot with 20 ml DI.'JE containing 15 % m:ISO (v/v). The 
final concentration of PEG is 44%. The media was removed 
from the mixed cell cultures by aspiration and 2 ml of the 
PEG-Df/ISO added to the cultures. After 1 min, the PEG-
DrJISO was removed by aspiration and the cells washed 4 times 
with DivlE supplemented with 15% DTJISO followed by 2 washes 
with DME alone. The resulting heterokaryon cultures ·were 
maintained on DNIE supplemented vli th 2% FCS. The fusion 
efficiency for these experiments was approximately 42% 
as determined from cultures stained with methylene blue. 
The heterokaryon cultures were harvested after 7 days and 
( O:v, 
lysed by 6 cycles~freezing and thawing in a dry ice -
acetone bath. The lysate was examined for infectious BKV 
.. 
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by plaque assay and by infection of HEK cells. Infected 
cells were observed for cytopathic effects and assayed for 
infectious virus by hemagglutination of human type 0 erythro-
cytes 21 days post-infection. 
Extraction of Cell DNA: Cell DNA was extracted as 
described by Boyd and Butel (9). Cells were harvested and 
resuspended to a density of 3 x 107 per ml in 0.05 M Tris-
HCl, 0.1 J.\1 EDTA, and 0.01 M NaCl pH 7.1 (TES buffer). 
For cell lysis, a 20% solution of sodium dodecyl sulphate 
(SDS) was added to a final concentration-of 0.5% and the su~ 
pension incubated at 37 C with periodic swirling. An 
equal volume of phenol saturated with TES buffer was added 
and the mixture shaken for 10-15 min. The phases were sep-
arated by centrifugation at 15,000 g for 10 min. The aque-
ous phase containing the DNA was removed and the procedure 
repeated 4 times. An equal volume of chloroform-isoamyl 
alc-ohol (24:1 v/v) was added to the aqueous phase and shak-
en for 5-10 min. The phases separated as before, and the 
aqueous phase collected. The solution was brought to 
0.1 M NaCl by addition of a 4 M stock solution of NaCl. 
Two volumes of cold absolute ethanol were layered on top 
of the aqueous solution and the DNA precipitated by winding 
onto a glass rod. The DNA was redissolved in 0.1 x sse. The 
sse concentration was adjusted to 2X by addition of 20X 
sse. RNAse A was added to a final concentration of 50 
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~g/ml and the solution incubated at 37 C for 2 hr. SDS was 
added to a final concentration of 0.5% and self digested 
pronase was added to a final concentration of 100/~g/ml. 
The solution was incubated at 37 C for 2 hr, after which the 
solution was extracted once with TES-saturated phenol and 
once with chloroform-isoamyl alcohol as described above. 
After the final chloroform-isoamyl alcohol extraction, the 
DNA was precipitated onto a glass rod by addition of 2 
volumes of cold absolute ethanol and redissolved in a 
minimum volume of 0.1 x sse (0.15 M NaCl, 0.015 M sodium 
citrate). The DNA was dialyzed against 3 1 of 0.1 x SSC 
overnight, and was stored at -20 c. The DNA was quanti-
tated by absorbance at 258 nm. 
Extrgc~ion of Viral DNA: Viral DNA was extracted from 
either infected cell extracts by the method of Hirt (37) 
or from whole virions. 
For Hirt extracted DNA, susceptible cells were infect-
ed at a multiplicity of 0.01 PFU/cell. At the first sign of 
viral cytopathic effect, the infected cells were washed 
three times in TES buffer and lysed by addition of 0.6% 
sodium dodecylsulphate in TES buffer. After 30 min incu-
bation at 37 C, the lysates were poured into acid-cleaned 
glass tubes and 5 M NaCl added to a final concentration of 
1 M. The tubes were gently mixed by inversion and refrig-
erated overnight at 4 c. The lysates were centrifuged at 
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15,000 rpm (Sorval SS-34 rotor) for 40 min. The pellet 
was resuspended in TES buffer. The DNA solution was combined 
with 1 gm of CsCl per milliliter of solution. Ethidium 
bromide v:as added to a :~inal concentration of 150 _;,..g/ml and 
the samples centrifuged at 35,000 rpm (Beckman Type 40 rotor) 
for ~-8 hr. DNA bands vrere visualized under an ultraviolet 
light and were collected from the gradient using a large 
bore pipette to minimize shearing effects. Purified viral 
DNA was dialyzed against TD bu .. ffer for 2L~ hr and quanti tat-
ed by absorbance at 258 nm. 
DNA Infectivity: A preparation of transformed cell DNA, 
containing approximately 400)\.g/ml was mixed with an equal 
volume of a 0.5 mg/ml solution of DEAE-dextran and 0.2 ml 
of the DNA-DEAE-D suspension inoculated per culture of semi-
confluent susceptible cells. The inoculated cultures were 
incubated for 30 min at 37 C after which the mono layers 
were washed with Tris-buffered 1BME) pH 7 .1. 
\ .. ,_/ 
The cultures 
were over layered with 2X DME containing 1.0% agar and 2% FCS. 
After 18 days, a second overlayer containing 2X DWE, 1.0% 
agar, and 0.005% neutral red was applied. The cultures were 
examined for plaques 24 hr later. 
Agarose Gel Electrophoresis: Electrophoresis through 
1.2% (wt/vol) agarose (Seakem) slab gels (20 em x 10 em x 
0.5 em) was carried out in a buffer consisting of 89 w~ 
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Tris, 2.5 mM EDTA, and 8.9 mM boric acid pH 7.8. Electro-
phoresis was for 9 hrs at 25 milliamperes which was su::'fi~ 
cient to clearly separate all DNA bands. The gels were 
stained with a solution of 2 ,Ag of ethidium bromide per 
milliliter o!: water and the stained DNA visualized under 
an ultraviolet light. 
Restriction Endonuclease Cleavage of Viral DNA: 
I. R. Eco RI - Reaction mixtures containing 100 ml\1 Tris 
pH 7.5, 50 mM NaCl, 5 mM MgC12 , 100A.g bovine serum albu-
min (BSA), 5 units of R Eco RI, and 2~g viral DNA were 
incubated for 1 hr at 37 C. 
II. R Hpa II - Reaction mixtures containing 10 w~ Tris pH 
2.5, 60 mM NaCl, 10 mlVI KCl, 100_Ag BSA, 20 units R Hpa II, 
and 2 )'l..g viral DNA were incubated for 1 hr at 37 C. 
III. R Hind III - Reaction mixtures containing 7 wfl Tris 
HCl pH 7. 9, 7 mm r~1gCl2, 60 mM NaCl, 100 .,.A.g BSA, 5 units of 
R Hind III, and 2~g viral DNA were incubated for 1 hr at 
37 c. 
All restriction endonuclease digestions were stopped 
by the addition of 10~1 of 5% SDS and the cleavage products 
fractionated by electrophoresis in 1.2% agarose gels in 
Tris-borate buffer ( 89 ml'ii Tris, 89 rlli·1 boric acid, 25 mTIT 
EDTA, pH 8.2) at 2 v / em for 10 hr. 
s1 nuclease mapping of viral DNA: The procedure for S1 
nuclease mapping has been described by Shenk et gl. (82). 
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Heteroduplexes of Eco RI endonuclease-generated linear 
BKV DNAs vmre prepared by denaturing a mixture containing 
l.J..,g each of the two DHAs in boiling water. After 5 min, 
NaCl was added to a final concentration of 0.2 m and the 
DNA was reannealed at 68 C for 3 min. The reannealed DNA 
was treated with s 1 nucelase (140 units /~g DNA) in the 
presence of 4.5 mM Znso4 , 280 mM NaCl, and 20~g/ml denatured 
calf thymus DNA. After 30 min at 25 C, the reaction was 
terminated by the addition of 0.05 volume of Tris base (2M) 
and by increasing the Na+ concentration to 500 mM. The DNA 
was electrophoresed on a 1.2% agarose gel in Tris-borate 
buffer (89 mm Tris, 89 mM boric acid, 25 mivT EDTA, pH 8.2) 
at 20 v for 10 hr. 
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Results 
Cell Tramj~QI.mations: Growth in agar suspension is 
considered the most stringent in yitrQ correlate for in 
vivo oncogenicity (83). The assay is based on the observ-
ation that normal cell growth is anchorage dependent, where-
as malignant or transformed cell growth is anchorage in-
dependent (52,83). To utilize this observation experiment-
ally, cell cultures were infected with BKV at a multipli-
city of 125 PFU/cell, and plated in O.JJ% agar at a den-
sity of 2. 0 x lOLJ- cells/plate. After J weeks, only BKV 
infected BHK-21 cells yielded transformants at a frequency 
of 0.4%, as shown in Table 1. Polyoma infected f2408 cells 
served as a positive control and grew at a frequency of 
1.6%. Ten colonies of each cell type, which were approx-
imately 1 mm in diameter, were cloned from the agar and 
characterized further. The plating efficiencies in agar 
suspension of each BK-BHK clone are shown in Table 2. 
Four of the BKV transformed BHK-21 cell lines (BK-BHK) 
maintained very high plating efficiencies. The Py2408 
cell lines, shown in Table J, were somewhat lower than 
the BK-BHK cell lines. 
The four BK-BHK cell lines with the highest plating 
efficiencies in agar suspension were examined for their 
ability to initiate tumors in hamsters. As shown in Table 
4, all of the BK-BHK cell lines tested initiated tumors 
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Table 1 Cell Transformation in A S . l gar uspens1on 
Infecting Cell Transformation2 Virus Tyne Efficiency <%) 
BKV BHK-21 0.4 
BKV HEFJ < o. 001 
BKV HEK <0.001 
BKV HEK-3TJ-L9 < o. 001 
BKV 73-ED-14 <0.001 
BKV H~ < 0. 001 
BKV RSF6 < o. 001 
Polyoma f2408 1.6 
None f'2408 <0.001 
None BHK-21 0.006 
1. Average-of four experiments 
2. Calculated as the number of colonies/number of infected 
cells plated X 100. 
3; Hamster embryo fibroblast cells 
4. Marmoset fibroblast cell explant 
5. Marmoset fibroblast cells 
6. Rabbit skin fibroblast cells 
Table 2 Agar Plating Efficiencies of BKY Transformed Ce)Js 1 
Cell Plating 2 Line Efficiency (%) 
RF-194.3 14.5 
BK-BHK-L-29 .38.0 
BK-BHK-L-28 .31.1 
BK-BHK-L-2.3 J0.5 
BK-BHK-L-19 27 • .3 
BK-BHK-L-18 9.6 
BK-BHK-L-16 5.6 
BK-BHK-L-14 12.6 
BHK-214 0.1 
I. Average of five experiments 
2. Calculated as the number of colonies/number of cells 
plated X 100. 
J. Positive control 
4. Negative control 
3.5 
Table 3 Agar Plating Efficiencies of Polyoma 
Transformed Cellsl 
Cell Plating 2 Line Efficiency (~) 
Py-2408-Cl-4 3.9 
Py-2408-Cl-5 .5.8 
Py-2408-Cl-6 6.4 
Py-24-08-Cl-7 7.6 
Py-2408-Cl-8 5.7 
Py-2408-Cl-10 2.8 
PySPlAJ 20.2 
f24o84 <0.001 
1. Average of two experiments. 
2. Calculated as the number of colonies/ 
number of cells plated X 100. 
J. Polyoma transformed hamster cell line 
used as a positive control. 
4. Negative control. 
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Table 4 Tumorigenicity of BK-BHK cells in Hamster~1 
Number of Number of Anim21s 
Cell Line Animals with Tumors 
RF-194 3 o3 
BK-BHK-L-29 3 3 
BK-BHK-L-28 
BK-BHK-L-23 
BK-BHK-L-19 
BHK-21 
HEF 
3 
3 
3 
3 
3 
1. Average of two experiments 
3 
3 
3 
0 
0 
2. Represents the number of animals with palpable 
tumors 21 days post inoculation. 
3 • .. Average appearance of palpable tumors was 54 days 
post inoculation. 
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in hamsters. This experiment verifies the in vitro cor-
relate for malignancy; that is, the agar suspension assay. 
The agar suspension assay is a very stringent assay 
for cell transformation. In some cases, cells which will 
initiate tumors in animals will not grow in agar sus-
pension. Therefore, for those cell lines yielding negative 
results in the initial agar transformation experiments, 
we attempted a variation of the agar suspension assay in 
an effort to increase the sensitivity for transformation. 
Cultured cells were infected with BKV at a multiplicity of 
1 PFU/cell. The cells were grown in liquid medium for 5 
to 10 passages and were plated in agar suspension. No 
observable colonies had appeared after 3 weeks in culture. 
Large T Antigen Expression in BKV-transformed Cells: 
Expression of nuclear T antigen was detected by an immuno-
fluorescence assay. The RF-194 cell line, which shows strong 
T antigen expression was used as a positive control in all 
experiments. Negative controls included BHK-21 cells 
and hamster embryo fibroblast cells from which RF-194 was 
derived. Tumor cell explants were also examined for T 
antigen response. In each case, the T antigen response of 
each tumor explant was identical to that of the parent 
inducing cell line. Th3 data are summarized in Table 5. 
As illustrated in Figure 2a, the RF-194 control cells were 
strongly T antigen positive. Several of the BK-BHK cell 
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Xable 5 Immunofluorescent Detection of BKV T Antigen 
Cell ]Jine 
RF-194 
BK-BHK-L-29 
BK-BHK-L-28 
BK-BHK-L-23 
BK-BHK-L-19 
BK-BHK-L-18 
BK-BHK-L-16 
BK-BHK-L-14 
BHK-21 
HEF 
HEK 
Ailti-BKV T 
Antiserum 
+ 
+ 
+ 
Uninoculated 
Hamster Serum 
2 
-
1. Indicates several positive nu.clei in each micro-
scopic field. 
2. Indicates the absence of positively staining . · 
nuclei from all microscopic fields. 
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Fi~re 2 Immunofluorescent detection of BKV T antigen 
in BKV transformed cells with anti-BKV T antigen serum. 
A) RF-194 positive control; B) BHK-21 negative control; 
C) BK-BHK-L-29; D) BK-BHK-L-28; E) BK-BHK-L-19. 
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lines were also T antigen positive (Figure 2d-2e). 
However, BK-3HK-I~-29 was ':2 antigen negative (Figure 
2c). As noted previously, the BK-BHK-L-29 cell line main-
tained a high plating efficiency in agar suspension and in-
duced tumors in hamsters. Because there is a low frequency 
of spontaneous transformation in BKV transformation exper-
iments, we decided to examine this unusual line further 
for evidence of BKV transformation and viral gene expres-
sion. 
Immunoperoxidase Assay for Detection of Large T 
Antigen: We attempted to develop an immunoperoxidase assay 
for BKV T antigens as a more sensitive means of detecting 
viral proteins. Initially, the technique described by 
Sternberger (90) was used. Hamster antiperoxidase serum 
was prepared and quantitated as shown in Table 6. The 
hamster peroxidase-antiperoxidase (PAP) complex was prepared 
as described earlier and was assayed for activity as shown 
in Table 7. No peroxidase activity was detected in the 
PAP complex. Using reagents obtained from Dr. R. M. Dough-
erty, we found that both the hamster PAP and rabbit anti-
hamster serum were unsuitable for use in these experiments. 
These results are shown in Table 8. The assay was modified 
by using peroxidase coupled hamster IgG (FOG) in place of 
hamster PAP. These i~~unological reagents were prepared 
as described earlier. Hamster FOG was eluted from a Seph-
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T~ble 6 Equivalence Point of Hamster Antiperoxidase 
Antiserum . 
Total Protein Antibody 
Peroxidase Precipitated Precipitated Supernatant 
Added(mg) (mg) (mg) Test 
0.05 0.6.3 0.58 excess ab 
0.075 0.945 0.87 excess ab 
0.1 1.265 1.16 excess ab 
0.125 1.575 1.45 no excess 
ab or ag 
0.15 1.51 1 • .36 no excess 
ab or ag 
0.175 1.46 1.285 slight 
excess ag 
0.2 1.41 1.21 slight 
excess ag 
1.0 0.22 excess ag 
1. Average of two experiments. 
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Table ? Activity of Peroxidase-Antiperoxidase Complexes 
Sample 
0.1 ml saline/0.1 ml peroxidase solution1 
0.1 ml saline/0.1 ml peroxidase substrate 
ActivitY 
0.1 ml peroxidase solution/0.1 ml peroxidase + 
substrate 
0.1 ml PAP/0.1 ml peroxidase substrate 
0.1 ml peroxidase conjugated rabbit anti-
hamster globulin (Cappel)/0.1 m1 
peroxidase substrate 
0.1 ml FOG/ 0.1 ml peroxidase substrate 
0.1 ml POG (Dougherty)/0.1 m1 peroxidase 
substrate 
1. 1.0 ug peroxidase/m1 saline 
+ 
+ 
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Table 8 Reactivitv of Imrnunoperoxidase Reagents1 
Anti-Viral Bridge fAfLfo~2 Cell Line S~r11m An:ti~ery,m Rea~:ti~m 
RF-194 268-APJ a-Ha-287-1 4 POG-35 4 ... 
RF-194 268-AP a-Ha-287-1 PAP-16 +/-
RF-194 268-AP a-Ha-287-1 PAP-26 +I-
RF-194 a-RF-37 a-Ha-l 8 PAP-1 +I-
RF-194 a-RF-3 a-Ha-287-1 POG-J J+ 
RF-194 268-AP a-Ha-l POG-J 
BK-BHK-L-19 268-AP a-Ha-287-1 POG-3 21' 
BK-BHK-L-28 268-AP a-Ha-287-1 POG-3 2+ 
BK-BHK-L-29 268-AP a-Ha-287-1 POG-J 
BHK-21 268-AP a-Ha-287-1 POG-J 
1. Outcome of two experiments was identical. 
2. Peroxidase-antiperoxidase complex or peoxidase conju-
. gated hamster IgG. 
3. Hamster anti-BKV T.serum (Dr. Dougherty) 
4. Rabbit anti-hamster IgG (Dr. Dougherty) 
5. Obtained from Dr. Dougherty 
6. Synthesized in this laboratory 
?. Prepared in this laboratory (Hamster anti-BKV T serum) 
8. Rabbit anti-hamster IgG serum prepared in this lab-
oratory. 
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adex G-100 columr:, as shown in Figure J. Practions from 
the first peak were pooled and concentrated by ultrafiltra-
tion. The immunological reactivity of all reagents was 
examined by diffusion in agar as shown in Figure 4. From 
these results, all reagents appeared to be suitable for the 
assay. However, no staining was observed when these rea-
gents were uced to detect T antigen. Staining was only ob-
served using reagents obtained from Dr. R. M. Dougherty. 
Although we were unsuccessful in developing an immunoperoxi-
dase assay for BKV T antigen, we were able to confirm the 
immunofluorescence data using the reagents obtained from 
Dr. Dougherty. (Figure 5). 
In addition, antisera against the BK-BHK cells was 
examined for its ability to detect T antigen. As shown in 
Table 9, no T antigen reactivity was detected in RF-19L.1- cells 
using antisera against BK-BHK-J.r29. Weak T antigen reac-
tivity was detected with antisera against BK-BHK-L-28, 
BK-BHK-L-19, and BK-BHK-L-23. In all cases, the response 
against T antigen in BK-BHK cells was weak or nonexistent. 
Absorption of Anti-BKV ~ Serum with Trans~ormed Cells: 
In order to further establish the lack of T antigen ex-
pression in the BK-BHK-L-29 clone, we absorbed anti-BKV 
T antigen antisera with BK-BHK-L-29 cells, and tested the 
absorbed serum for T antigen reactivity. The results were 
inconclusive. Reactivity against large T antigen was non-
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.. 
.. 
Figure 3 Elution profile of peroxidase-conjugated hamster 
IgG from an 82 em x 1.5 em Sephadex G-100 column. 
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. · 
Figure 4: Immunoreactivity of reagents us~d in the POG 
assay for viral T antigen. Center well: peroxidase-con-
jugated rabbit anti-hamster-IgG, 1) hamster POG, 2) 
goat anti-peroxidase, J) hamster IgG, {~mmonium sulfate 
precipitated), 4) rabbit anti-hamster IgG(Cappel Inc), 
5) hamster IgG(Cappel Inc), 6) rabbit anti-hamster IgG 
purified ·; iri this>; laboratory; 
· .. 
,·· 
.. 
Eigure s~ Immunoperoxidase detection of BKV T antigen 
in BKV transformed cells using hamster anti-BKV-T antigen 
serum. A) RF-194, B) BHK-21, C) BK-BHK-L-29, D) BK-BHK-L-28, 
E) BK-BHK-L-19. 
E 
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Table 9 T antigen Detection Using Anti-BK-BHK Antisera_ 
Anti-Cell 
Serum 
RF-194 
BK-BHK-L-29 
BK-BHK-L-28 
BK-BHK-L-2.3 
BK-BHK-L-19 
Uninoculated 
hamster serum 
Test Cell 
Line 
RF-194 
RF-194 
RF-194 
RF-194 
RF-194 
RF-194 
T-Antigen 
Response 
+ 
~I­
+ I-
+I-
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sp8cifically "J.bsorbed out by BK-BHK-I,-29, R~:.'-194, ancl BEK-2l 
cells. This may have been due to either an initial low 
antibody titer or because of the dilution of the serum during 
the cell absorptions as has been previously reported by 
t . . (r'"' o her exper1men~ers. .J~J. 
Virus Rescue Usin.z Sendai-mediated Cell Fusion: The 
BK-BHK and Py2408 cell lines were examined for their abil-
ity to release infectious virus after cell fusion using 
BPL-inactivated Sendai virus. Initially, we were interest-
ed in determining the toxicity of active and inactive BPL 
on growing cells. Confluent monolayers of BHK-21 cells 
were treated with several concentrations of either 
active or inactive BPL as described. The cell cultures 
were harvested after 24 hr, and the plating efficiency 
of the BPL-treated BHK-21 cells determined. As shown in 
Table 10, there was no significant difference in the number 
of cells harvested from each of the BPL-treated cell cul-
tures. The only notable effect of BPL was on the viability 
of the cells. Cells that were treated with BPL that had 
been inactivated by heating to 37 C for 30 min at a concen-
tration of 0.0125% plated with a high efficiency of 4?.2%. 
No cell growth was observed for concentrations of BPL 
greater than 0.0125%, regardless of inactivation. 
In order to inactivate Sendai virus, and avoid the cell 
toxicity effects of BPL, a killing profile was constructed. 
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Table 10 Effects of 0-Propiolactone on BHK-21 Cells 
Actiye lnactive1 
BPL (%) 
0.1 
0.05 
0.025 
0.0125 
0.00625 
Untreated 
Cells per6 Plate(x 10 ) 
1.9 
5.26 
1.0 
1.24 
).85 
4.8 
0 
0 
0 
0 
0 
58.) 
Cells per6 flate(x 10 ) PE 
1.2 0 
5.25 0 
1.17 0 
2.12 47.2 
6.1 48.8 
5.4 51.1 
1. BPL was inactivated by heating at 37 C for JO min. 
2. Plating efficiency was calculated as the number of 
colonies/number of cells plated x 100. 
51 
Sendai virus was treated with several concentrations of 
BPL. The virus was inoculated into 9 to 10 day old embry-
onated chicken eggs, and the allantoic fluids assayed J 
days later for hemagglutinating activity. As shown in 
Table 11, Sendai virus was inactivated at all concentra-
tions of BPL tested. As a result of these experiments, 
Sendai virus was routinely inactivated at a BPL concentra-
tion of 0.0125%. 
Cells were fused in the presence of 4000 HAU of BPL 
inactivated Sendai virus as described. As shown in Table 
12, infectious virus was rescued only from Py2408 cells. 
No infectious virus was released from any of the BK-BHK 
cell lines using this technique. 
Virus Rescue Using PEG-DMSO Mediated Cell Fusion: 
Norwood et al. (64) have reported on increases in the effi-
ciency of cell fusion using polyethylene glycol and dimethyl 
sulfoxide mixtures. Using this technique, infectious virus 
was rescued from J of the BK-BHK clones as shown in Table 
1). It should be noted that infectious virus was rescued 
only when BK-BHK cells were fused with HEK cells. Virus 
was not released after treatment of BK-BHK cells alone, in-
dicating that PEG-Dr.'ISO was not inducing virus replication 
alone. Also, virus was not released from normal BHK-21 
cells or HEK cells indicating that the source of the virus 
was the BK-BHK cells. The infectious virus was serologi-
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Table 11: BPL Killing Profile on Sendai Virus 
Concentration Hemagglutinatin! 
BPLC%) Units Recovered 
0.1 0 
0.05 0 
0.025 0 
0.0125 0 
0.00625 0 
untreated 1024 
1. 125 hemagglutinating units of Sendai virus 
were treated with the BPL concentrations as 
as described and inoculated into embryonated 
hens eggs. This value represents the amount 
of virus recovered after 3 days incubation 
as described. 
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Table 12: Sendai Mediated Virus RescuQ___ 
Cell 
Line 
RF-194 
BK-BHK-L-29 
BK-BHK-L-28 
BK-BHK-L-23 
BK-BHK-L-19 
BK-BHK-L-18 
BK-BHK-L-16 
BK-BHK-L-14 
Py2408-Cl-5 
Py2408-Cl-6 
Py2408-Cl-7 
BHK-21 
f2408 
Permissive 
Host Cell 
HEK 
HEK 
HEK 
HEK 
HEK 
HEK 
HEK 
HEK 
Balb c/3T3 
Balb c/JT3 
Balb c/3T3 
HEK 
Balb c/3T3 
Virus Rescued1 (PFU/ml) 
0 
b 
0 
0 
0 
0 
0 
0 
6.0 X 101 
3.2 X 103 
2.2 X 102 
0 
0 
1. PFU/ml of a h~terokary~n lysate 
consisting of 1.0 x 10l fused cells. 
54 
Table 1): Virus Rescue Following PEG-DMSO Fusion 
Ce1 l Line 
Permissivi 
Host Cell Virus Rescued2 
RF-191~ HEK 0 
RF-194 HEK-3T3-L-9 0 
RF-194 none 0 
BK-BHK-L-29 HEK 1.0 X 103 
BK-BHK-L-29 HEK-3T3-L-9 0 
BK-BHK-L-29 none 0 
BK-BHK-L-28 HEK 2.0 X 102 
BK-BHK-L-28 HEK-3T3-L-9 0 
BK-BHK-L-28 none 0 
BK-BHK-L-23 HEK 0 
BK-BHK-L-23 HEK-3T3-L-9 0 
BK-BHK-L-23 none 0 
BK-BHK-L-19 HEK 1.4 X 102 
BK-BHK-L-19 HEK-3T3-L-9 0 
BK-BHK-L-19 none 0 
BK-BHK-L-llJ- HEK 0 
BK-BHK-L-14 HEK-3T3-L-9 0 
BK-BHK-L-14 none 0 
BHK-21 HEK 0 
BHK-21 HEK-3T3-L-9 0 
BHK-21 none 0 
1. Cells were either self-fused or fused with a permissive 
host cell line. 
2. Infectious titer of a heter~~aryon cell lysate 
containing approximately 10 cells. 
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cally identified as BKV by inhibition of hemagglutination 
and neutralization of infectivity using BKV specific hyper-
immune rabbit antisera. (Tables 14 and 15). 
The finding that the T antigen negative BK-BHK-L-29 
clone releases infectious virus was unexpected, since 
T antigen is thought to be necessary for papovavirus trans-
formation. It was important to determine if the lack of T 
antigen expression in these cells was a stable character-
istic, or only transient as has been reported in some cases 
in other systems (44). Subclones of several of the parent 
BK-BHK clones were examined for their ability to express 
T antigen and release infectious BKV after cell fUsion. 
As shown in Table 16, each subclone maintained the charac-
teristics of the parent clone. Most importantly, subclones 
of BK-BHK-L-29 were all T antigen negative virus yielders, 
indicating that this is a stable characteristic. 
In order to determine whether T antigen synthesis was 
induced by heterokaryon formation, the BK-BHK-L-29 cells 
were fused with HEK cells, and the heterokaryons examined 
for T antigen expression 24 hr post-fusion. T antigen could 
not be detected. Virus production in heterokaryons is 
inefficient, about 10-6/heterokaryon (107). Given this low 
efficiency of virus rescue, it is possible that T antigen is 
expressed in the minority of heterokaryons that produce virus. 
Trgnsfection With Transformed Cell DNA: Boyd and Butel 
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~al21~ 14 Serological Identification of' Rescued Virus 
6 Titer Without Titer With ~am12J.~ Anti-BKV S~rum An:ti-BKV S~;rym1 
BKV-2922 1:256 0 
BKV-2813 1:128 0 
BKV-1914 1:128 0 
BKV-914765 1:512 0 
1. Virus samples were incubated with anti-BKV serum 
before titration by hemagglutination assay. 
2. Virus ref!tcued from BK-BHK-L-29 
J. Virus rescued from BK-BHK-L-28 
4. Virus rescued from BK-BHK-L-19 
5. Wild type BKV 
6. No inhibition of hemagglutination was observed 
using uninoculated rabbit serum. 
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Table 15 Neutralization of BKV1Infectivity with Anti-BKV Serum 
Virus Serum 
Challen2e 
Titer 
Neutralization 
Titer3 
BKV-292 anti-BKV 3.5 X 102 0 
BKV-292 normal 4 3.5 X 102 J.l X 102 
BKV-PI-185 anti-BKV 5.1 X 102 0 
BKV-PI-18 normal 5.1 X 102 4.9 X 102 
1. Anti-BKV serum was challenged with a predetermined 
amount of infectious BKV and the serum neutralizing 
effects quantitated by plaque assay on HEK cells. 
2. Titer without anti-BKV serum. 
J. Titer after incubation with anti-BKV serum. 
4. Uninoculated rabbit serum. 
5. Wild type BKV. 
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Table 16 Virus Rescue and T Antigen Response in BK-BHK 
Subclones 
Cell Line 
BK-BHK-L-29 
BK-BHK-L-29-a 
BK-BHK-L-29-b 
BK-BHK-L-29-c 
BK-BHK-L-29-d 
BK-BHK-L-29-e 
BK-BHK-L-28 
BK-BH'n:-L-28-a 
BK-BHK-L-28-b 
BK-BHK-L-28-c 
BK-BHK-J_,-28-d 
BK-BHK-L-23 
BK-BHK-L-23-a 
BK-BHK-J_,-23-b 
BK-BHK-L-23-c 
BK-BHK-L-23-d 
BK-BHK-L-19 
BK-BHK-L-19-a 
BK-BHK-L-19-b 
BK-BHK-L-19-c 
BK-BHK-L-14 
BK-BHK-L-14-a 
BK-BHK-L-14-b 
BK-BHK-L-14-d 
BHK-21 
Titer of 2 Virus Rescued 
6.7 X 103 
3.9 X 10~ 
4.9 X 102 5.0 X 103 1.8 X 102 2.5 X 10 
2.0 X 10i 
2.0 X 102 3.4 X 101 5.0 X 101 5.0 X 10 
0 
0 
0 
0 
0 
2 1.4 X 103 1.0 X 102 4.6 X 102 7.5 X 10 
0 
0 
0 
0 
0 
1. Average of three experiments 
T Antige~ 
Response 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
2. Plaque titer in PFU/ml of a7lysate of heterokaryons containing approximately 10 cells. 
3. Determined by immunofluorescence assay 
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(9) have been able to rescue infectious SV40 from previously 
non-rescuable SV40 transformed cell lines, termed non-yield-
ers, by trans:fection of permissive cells with transformed 
cell DNA. ~e examined BK-BHK cells for their ability to 
release infectious BKV using the DEAE-dextran technique. 
We included wild type BKV DNA as a positive control. As 
shown in Table 17, we were unable to rescue infectious 
virus from any of the BK-BHK cell lines using this technique. 
Using BKV DNA, infectious virus was produced at a titer of 
3.89 x 103 PFU,?\.g viral DNA. Because of this low infectiv-
ity of viral DNA, the chances of detecting infectious BKV 
DNA in transformed cell DNA where it is about 104-fold less 
concentrated, are very small. Therefore, this method 
appeared to be unsuitable for examination of virus rescua-
bility. 
Biological Characteristics of BKV-292: The BK-BHK-Ir29 
cell line is large T antigen negative, but also a virus 
yielder. This suggests the possibility that the virus tran~ 
forming these cells may have been a variant of BKV, defective 
for large T antigen synthesis. If the transforming virus 
was unable to induce large T antigen synthesis, then this 
should be reflected in the ability of the rescued virus, 
BKV-292, to induce large T antigen synthesis in transformed 
cells. Hamster cells were infected with either wild type 
BKV or BKV-292 at a multiplicity of 100 PFU/cell. The tran~ 
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Table 17: Virus Rescue by Transfection 
with Transformed Cell DNA 
DNA 
Source 
RF-194 
BK-BHK-L-29 
BK-BHK-Ir28 
BK-BHK-L-19 
BHK-21 
Permissive 
Cell Host 
HEK 
HEK-3T3-L-9 
HEK 
HEK-3T3-L-9 
HEK 
HEK-3T3-L-'9 
HEK 
HEK-JTJ-L-9 
HEK 
HEK-3T3-L-9 
HEK 
HEK-JTJ-L-9 
Virus Yield 
(PFU/ug DNA) 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1. DNA extracted fDom wild type BKV-61677 
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forming efficiency of wild type BKV and B}CV-292 v:ere corn-
parable (Table 18). Several of the BKV-292 transformed 
colonies were cloned from the agar and examined for large T 
antigen expression and ability to rescue infectious virus. 
As shown in Figure 6, BKV-292 does induce large T antigen 
in BKV-292 transformed cells. The results are summarized 
in Table 19. Five of the BKV-292 transformed cell lines 
expressed BKV large T antigen. Infectious BKV could be 
rescued from only one of these cell lines. In no case was 
a large T antigen negative virus yielder observed. It should 
be noted that although the parental BK-BHK-L-29 clone res-
cued infectious BKV, virus rescuability in clones transformed 
by BKV-292 was variable. It appears, therefore, that virus 
rescue is not a stable characteristic dependent upon the 
transforming virus, but is rather a cell dependent proper-
ty which may vary within a given cell population. 
Examination o:f BKV-292 DNA: Simultaneously with the 
biological characterization o:f BKV-292, we examined the DNA 
of the rescued virus :for genetic alterations. Initially, 
the viral DNA was screened :for large deletions or insertions 
by calculating its molecular weight on a 0.?% agarose gel. 
The DNA of BKV-292 comigrated with wild type BKV-DNA which 
had a kno·..vn molecular weight o:f J. 25 x 106 dal tons. Howley 
.fU al. (J8) and Yang and Wu (Ill+), have demonstrated that 
the DNA fragments produced by trea,tment with the restriction 
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Table 18: Transforming Efficiency of BKV-292 
Infecting 
Virus 
BKV-292 
BKV-PI-18 
Uninfected 
Cell 
Infected 
BHK-21 
BHK-21 
BHK-21 
Transformatio£ 
Efficiency(%) 
0.49 
0.53 
0.02 
1. Calculated as the number colonies/number cells 
plated x 100. 
.·· 
·. 
~. ' 
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Figure 6: Immunofluorescent detection of BKV T antigen 
using hamster anti-BKV-T antigen serum. A) BKR-2912, 
B) BKR-2918, C) BKR-2919. 
Table 19 Characterization of BKV-292 Transformed Cells1 
Cell Line 
RF-194 
BK-BHK-L-292 
BKR-29103 
BKR-2912 
BKR-2913 
BKR-2914 
BKR-2916 
BKR-2917 
BKR-2918 
BKR-2919 
BHK-21 
T Antigen 
Expression 
+ 
+ 
1. Results of three experiments. 
Virus 
Rescuability 
+ 
+ 
2. Used as a positive control for virus rescue. 
3. BKR designates the cell. lines transformed by the 
rescued virus BKV-292. 
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endonucleases Hpa II and Ei:(J.ci III a:ce not lclentl.cal for dlf-
ferent BI~V isolates. The DNA of the original 3KV isolate 
is cleaved 4 tines by Hind III while no cl·;:;avage occurs 
using Hpa II. In contrast, the BI:v-r.T:t strain, which 'Nas 
isolntec~ from a patient Vii th ':lisiwtt-/;.ldrich syndrome ( 100), 
contains only J Hind III cleavage sites, and in addition, is 
cleaved by Hpa II once near the origin of viral DNA replica-
tion. Based on these reports, vre compared wild type BKV 
and BKV-292 DNA fragments generated by these two enzymes. 
As shown in Figure 7, both isolates contain a Hpa II cleav-
age site. Figure 8 illustrates that the fragments gener-
ated by Hind III are indistinguishable between these two 
isolates. 
Recognizing that the chance of finding a genetic 
alteration by this method was small, we examined the DNA 
of wild type BKV and BKV-292 by the s1 nuclease mapping 
technique described by Shenk fti gl.(82). S1 attacks only 
single stranded DNA. It will also attack DNA heteroduplexes 
with a minimum of about a J base pair difference betvmen 
two DNA molecules (110, Subramanian, personal communication) 
The circular DNA's were converted to linear forms by treat-
ment with the restriction endonuclease Eco RI, which pro-
duces a single breals::. Equal amounts of the DNA samples 
were mixed, heat denatured and annealed at 68 C for 3 min. 
The annealed mixture of homoduplex DNA was scored for 
. · ~ . 
·. 
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Figure 7 Comparison of wild type BKV and BKV-292 DNA 
after digestion with the restriction endonuclease Hpaii. 
DNA samples were digested as deseribed and 0.5-1.0 ug 
digested DNA placed on a 1.2 % agarose gel. The DNA 
was electrophoresed as described in Materials and Methods 
and was stained with ethidium bromide. A) BKV-292 DNA 
undigested; B) BKV-292 DNA digested with Hpaii; C) Form 
I wild type BKV DNA .undigested; D) Form I wild type BKV 
DNA digested with Hpaii. 
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Figure 8: Comparison . df wild type BKV, BKV-292, BKV res-
cued from BK-BHK-L-19 (B~I-191), and BKV rescued from 
BK-BHK-L-28 (BKV-281) DNAs. DNA fragments were produced 
after digestion with restriction endonuclease Hind III 
and 0.5-1.0 ug digested DNA placed on a 1.2 % agarose gel. 
A) Wild type BKV DNA, B) BKV-191 DNA, C) BKV-281 DNA, 
D) Bh.'"V-292 DNA. 
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heterojuplexed regions oy S1 t~eatm9nt. After treatment, 
the DP:As vrere fractionated by electrophoresis on a l. 2% 
agarose gel. The results are shown in Figure 9. s1 
treatment of homoduplexes of each viral DNA yielded a single 
linear band with the exception of BTC'l-PI-18 (?igure 7C). 
Several minor bands ·were detected in this DNA which may be 
due to imperfect reannealing under these conditions. Alter-
natively, some mutant BKV DNA may be present. However, this 
was not detected in the previous restriction endonuclease 
cleavage experiments (Figures 7 and 8). Lane G of Figure 
9 is a crude Hirt extracted wild type BKV DNA used as a 
marker. The lowest band represents form I DNA, while the 
middle band is form II DI\:A. The uppermost band is cell DNA. 
s1 treatment of the positive controls consisting of annealed 
wild type SV4-0 and SV40 dl 1635 gave the expected J bands 
(Figure 9E). The faster migrating bands represent the 
two_products of S1 cleaved heteroduplex DNA. The slowest 
migrating band.consists of resistant homoduplex DNA. 
No rapidly moving DNA species were generated by s1 
treatment of annealed wild type and BKV-292 DNAs. Rather, 
the s1 treated DNAs migrate with the linear viral unit genome 
controls. Thus the rescued BKV-292 is indistinguishable from 
wild type Bl\'"V. It must differ by less than J base pairs. 
.·· 
Figure ~ Comparison of wild type BKV and BKV-292 DNA 
after hybridization and treatment with s1 endonuclease. 
The DNA of each virus was converted to li~ear form by 
treatment with EcoRI. The DNAs were hybridized, digested 
with s1 , and electrophoresed on a 1.4% agarose gel. 
The DNA was visualized by staining with ethidium bromide. 
A) s1 treated self-hybridized SV40 wild type DNA; B) s1 
treated self-hybridized SV40 dl 1635 DNA; C) s1 treated 
self-hybridized wild type BKV DNA; D) s1 treated self-
hybridized BKV-292 DNA; E) s1 treated wild type SV40/ 
SV40 d1 1635 DNA hybrids; F) s1 treated wild type BKV/ 
BKV-292 DNA hybrids; G) untreated, crude Hirt extracted 
wild type BKV DNA. 
A B c D E F G 
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Discussion 
We have examined the relationship between the early 
gene expression in BKV transformed BHK-21 cells, and the 
functional state of the viral genome within these cells. 
The BK-BHK cells were initially transformed in agar suspen-
sion and maintained high plating efficiencies in agar sus-
pension throughout our studies. All of the BK-BHK clones 
tested initiated tumors in hamsters. The efficiency of BKV 
transformation is low occurring at a frequency of about 
0.4% (Table 1). We were unable to transform rabbit or 
primate cells with BKV. The efficiency of BKV infection 
of these cell types may be low, although BKV transforma-
tion of rabbit and rhesus monkey cells has been reported 
(10,56,70). Dougherty (18) and Shah u .a,l. (80) have shown 
that the oncogenicity of BKV isolates differ. It may be 
that the ability to transform cells in Y.i:tr.o. may also differ 
between isolates. 
Data accumulated to date have suggested that large T 
antigen is necessary for the maintenance of transformation 
(11,47,55,66,102). These data have been based primarily 
on experiments with conditional lethal mutants of SV40. 
Cells transformed by these mutants are temperature sensi-
tive for transformation. The T antigen in these cells has 
altered properties which has led to the conclusion that T 
antigen is necessary for cell transformation. BKV T antigen 
?1 
expression in BK-BHK cells is weak. In several BK-BHK 
clones, BKV T antigen could not be detected by immunofluor-
escence assay. We attempted to develop an immunoperoxidase 
assay for viral antigens as a more sensitive means for de-
tection of viral gene products. The immunoperoxidase assay 
has been reported to be 10 to 100 times more sensitive than 
immunofluorescence assays for viral antigens (20,90). 
However, we were unsuccessful in developing such an assay 
for BKV T antigens. Each immunological component was tested 
for reactivity against each of the other assay components 
by double diffusion in agar (Figure 4). Individually, the 
components were immunologically reactive. The hamster anti-
T antiserum was shown to be reactive in the immunofluorescence 
assay forT antigen (Figure 2). The rabbit anti-hamster 
and POG complex appear to be reactive immunologically by 
this method. In addition, the FOG complex was reactive in 
the assay for peroxidase activity described earlier. How-
ever, when the reagents were used in a peroxidase assay for 
T antigen on T-positive RF-194 cells, no reactivity was 
detected. At this time, we have no explanation for the 
observed lack of reactivity. However, we were successful 
in performing the assay using reagents obtained from Dr. 
R. M. Dougherty. With these reagents, we were able to show 
that the T antigen response of the BK-BHK clones was consis-
tent, whether the method of detection was immunofluorescence 
or immunoperoxidase assays (Tables 5 and 8). In our hands, 
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the sensitivity of the immunoperoxidase assay was no greater 
than immunofluorescence assay for viral T antigen. We 
accordingly used the immunofluorescence assay for detecting 
viral T antigen, as it provided a more reproducible assay. 
In order to establish the functional state of the viral 
genome in BK-BHK cells, we tried several methods for rescu-
ing infectious virus. There were several possible results 
anticipated in attempting to rescue infectious BKV from the 
BK-BHK cells. The entire BKV genome might be present in the 
transformed cells, and might exist in a rescuable state. 
Alternatively, the BKV genome might be present in a non-res-
cuable state. For example, if integrated; the DNA might not 
be efficiently excised, or possibly only a fragment of the 
genome might be present. A last possibility is that the sy~ 
tern used for examining virus rescuability might not be sens~ 
tive enough to allow virus rescue. Rescue by different met~ 
ods was necessary to rule out this possibility. All methods 
for rescuing DNA viruses from these transformed cells involve 
either cell fusion or DNA transfection. We were unable to 
rescue infectious BKV from any of the BK-BHK cells using 
Sendai mediated cell fusion. However, infectious polyoma 
virus was rescued from Py2408 cells using this technique. 
The inability to rescue infectious BKV using Sendai-mediated 
cell fusion is probably due to the inefficiency of cell 
fusion by this method. It has been reported that the per-
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centage of cells fused using Sendai virus is less than 15% 
(39). Of the heterokaryons formed, only 0.5- 5% will release 
virus (107). We were also unable to rescue BKV using DNA 
transfections. Since our data shov.r a lov1 ar.1ount of infecti \.,._ 
ity of the BKV DNA per microgram used, we concluded that this 
too is an inefficient means of rescuing BKV from BK-BHK cells. 
BKV DNA is present at a low copy number of 3 to 5 copies 
per cell genome in these cells, and therefore, would be und~ 
tected (53). 
Norwood et g].. (64) have reported a method for increas-
ing the efficiency of cell fusion using polyethylene glycol 
and dimethylsulfoxide. Fusion efficiencies of greater than 
50% have been achieved by this method (64). This is the 
most efficient method for cell fusion reported to date. 
We felt the increased efficiency of cell fusion might in-
crease the chances of detecting virus release. Using this 
technique, infectious BKV was rescued from three of the 
BK-BHK clones(Table 13). The rescued virus was identified 
serologically as BKV (Tables 14 and 15). The amount of 
infectious BKV released from each of the BK-BHK clones was 
much lower than that reported for SV40 rescue (108). 
T antigen is thought to be necessary for viral DNA 
replication and the maintenance of cell transformation. 
Thus the isolation of the T antigen negative virus yielder 
clone, BK-Bh'K-L-29 ·was a striking and unexpected result. 
It was important to determine if these characteristics were 
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stable or on::.y tra~1sient as has been repo:ct2ci for certain 
SVI+O trans::'orm(~d coll lines (L~L~). Each JK-3HK cell 1 ine 
was subcloned and the subclones examined for their ability 
to rescue BKV and express fT1 -J-• J.. anvlgen. Each subclane maint~i~ 
ed the of the parent cell line. Hetero1:a:::-y-
ons of BK-BillC-L-29 and HEK cells were examined and found to 
be T antigen negative. These results confirm that the BK-
BHK-L-29 clone is T antigen negative and yet a virus 
yielder. 
We investigated the possibility that the lack of T 
antigen expression might be due to the loss of a viral 
function. It is possible that the BK-BHK-L-29 cell line 
was transformed by a variant BKV species which i'las defect-
ive for T antigen expression. If this were true, then the 
defective nature of the transforming virus should be re-
fleeted in the rescued virus, BKV-292. This defect would 
be in the form of a biochemically detectable alteration 
in the viral genome, specifically in the region coding for 
T antigen. In addition, a genetic alteration would be 
reflected in the biological properties of the virus. 
If large T antigen is necessary for cell transformation, 
then a BKV isolate defective for T antigen synthesis should 
induce cell transformation at a significantly lower fre-
quency. As stated previously, BKV isolates are known to 
differ in their restriction endonuclease maps (38,114). 
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Based on these reports, the DNA of BKY-292 was compared to 
wild type BKV DNA by examining the DNA fragments produced 
by the restriction endonucleases Hpa II and Hind III. 
The wild type BKV contains a R-Hpa II cleavage site which 
is preserved in the rescued BKV-292 DNA (Figure ?). No 
difference was detected after digestion of BKY-292 and wild 
type BKV DNA with R-Hind III (Figure 8). Recognizing that 
the chance of finding a genetic alteration by this method 
was small, the DNA of BKV-292 was examined by the s1 
nuclease mapping technique of Shenk ~a!· (82). The DNA 
of BKV-292 was hybridized to wild type BKV DNA after conver-
sion to linear forms, and the hybrids treated with the sin-
gle strand specific endonuclease S1• Theoretically, this 
technique should detect a single base mismatch. However, 
in practice, the lower limit is approximately a 3 base 
mismatch (110, Subramanian, personal communication). 
Given this limit to the technique, the DNA of BKV-292 was 
homologous to wild type BKV DNA (Figure 9). 
Since BKV-292 was genetically indistinguishable from 
wild type BKV, we examined fUrther the biological character-
istics of the rescued virus. BKV-292 induced transformation 
of BHK-21 cells with an efficiency comparable to wild type 
BKV (Table 18). Upon further examination of the BKV-292 
transformants, we noted that infectious BKV could be res-
cued from one clone, BKR-2912. More importantly, T antigen 
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was detected in several of the BKV-292 transformed cells 
(Table 19). These results confirm the biochemical data on 
the genetic makeup of BKV-292. From this, we have concluded 
that BKV-292 is essentially wild type. 
There are several possible explanations for the observed 
characteristics of the BK-BHK-L-29 clone. It is possible that 
the BK-BHK-L-29 clone is actually a spontaneously trans-
formed BHK-21 cell line which passively carries BKV. The 
transformed characteristics are due to a cell genome alter-
ation. The BKV genome is not actively expressed; however, 
it can be rescued by cell fUsion. This is an unlikely pos-
sibility. The frequency of BKV transformation·was 0.4% 
while the frequency of spontaneous transformation was 
o.oo6%. The frequency of formation of a spontaneously 
transformed BHK-21 cell passively infected with BKV is the 
product of these two frequencies or 0.0024%. Because of' 
this low frequency, this possibility appears unlikely. 
A more complex explanation of the characteristics of 
BK-BHK-L-29 involves the possibility of a two step mutant-
revertant BKV. Initially, transformation may have been C!aused 
by a mutant of BKV. This mutant might be unable to induce 
T antigen but is fUlly capable of inducing transformation. 
However, when virus rescue occurs, the mutant BKV may 
revert to wild type. Presently, we cannot assess this 
hypothesis as we have no way of examining the genetic com-
position of the transforming virus without virus rescue. 
?? 
The least complex explanation of the data is that the 
inability to express T antigen may then reside with the host 
cell. Takemoto ~ al· (98) have previously reported isola-
tion of polyoma virus infected human fibroblast cells which 
synthesize T antigen, but do not express a transformed 
phenotype. Similar results have been reported by Noonan 
~ Ql. (6J) for SV40 infected rhesus monkey cells. These 
data indicate the T antigen, as detected by immunofluor-
escence assay, may not be sufficient for transformation. 
It.is possible that a low level ofT antigen is synthesized 
in these cells which is not detectable by histochemical 
assays. If this were true; however, one would not expect 
rescue of BK virus with an efficiency comparable to the T 
antigen positive clones. Also, if low level T antigen 
expression was undetected, it would be possible that some 
of the subclones of the T antigen negative cells may even-
tually s~ow some T antigen positive cells. This was never 
observed.· 
A more probable explanation would be that small t anti-
gen, detected only by immunoprecipitation techniques, is 
synthesized and functional (15). Conceivably, BK virus 
transformation may occur in the absence of detectable large 
T antigen. Recently, Hutchinson ~ al· (42) have reported 
the presence of small t antigen in the absence of large 
T antigen in polyoma transfomred BHK-21 cells. Our assays 
for T antigen were designed to detect the large T antigen. 
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Small t antigen has only been described after. immunoprecipi-
tation of viral proteins from transformed cells {15). There-
fore, it might be possible that small t is expressed in the 
BK-BHK-L-29 clone in the absence of large T antigen. If 
small t antigen is present in the absence of large T, then 
this may elucidate the fUnctions of small and large T anti-
gens for,BKV. 
' 
One possibility for a cell defect is the mRNA splicing 
system. Berk and Sharp {5) have shown the mRNA transcripts 
' encoding large and small T antigens are spliced differently. 
Therefore, the host cell defect may lie in the cellular 
ability to correctly splice the mRNA molecules in order 
for proper expression of viral genes. These possibilities 
are currently under investigation and should provide evidence 
for the function of the BK virus early gene products. 
1. 
2. 
4. 
6. 
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APPENDIX A 
Virus 
BKV-PI-18 
BKV-91476 
BKY-292 
BKV-281 
BKV-191 
SV40 strain 776 
SV40 dl 1635 
Polyoma 
Sendai 
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APPENDIX A 
Comments 
plaque purified wild type BKV 
plaque purified wild type BKV 
BKV rescued from BK-BHK-L-29 
BKV rescued from BK-BW~-L-28 
BKV rescued from BK-BHK-L-19 
wild type SV40 
SV40 deletion mutant with a 55 base 
pair deletion at 0.715-0.73 on the 
SV40 map 
wild type polyoma virus 
obtained from Microbiological 
Associates 
APPENDIX B 
Cell Line 
HEK 
HEK-.3TJ-L9 
HF 
73-ED-1 
BSC-1 
RSF 
HEF 
BHK-21 
f'2408 
Balb c/JTJ 
Py2408 
PySPlA 
RF-194 
BK-BHK 
BKR 
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APPENDIX B 
S . .eoo··l pec1es 0+ r1~1n 
human embryonic kidney 
human embryonic kidney 
marmoset monkey 
marmoset monkey 
African green monkey kidney 
rabbit skin fibroblasts 
hamster embryo fibroblasts 
baby hamster kidney5 
rat fibroblasts 
mouse fibroblasts 
rat fibroblasts 
hamster fibroblasts 
hamster fibroblasts 
baby hamster kidney (BHK-21) 
baby hamster kidney (BHK-21) 
2 Phenotype 
p 
p 
c 
p 
p 
c 
p 
p 
T(polyoma)6 
T(polyoma) 
T(BKV) 
T(BKV) 
T(BKV-292) 
1. \\All cell lines were obtained from either Dr. E.O. 
···\Major or Dr. G. di Mayorca. 
2. Denotes whether a particular cell is normal or 
transformed. 
J. Denotes normal primary or secondary cell line 
4. Denotes contim>us cell line 
5. Stoker and MacPherson (92) 
6. Denotes transformed cell line 
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